← all signals · sectors · research
Celldex Therapeutics, Inc. CLDX
SIC 2835 — In Vitro & In Vivo Diagnostic Substances · CIK 744218
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2025 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2022 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2019 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2015 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2013 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
Methodology: /methodology · Live JSON: /api/company/744218/financials